Open Access

Effect of Vasoactive Intestinal Peptide (VIP) on Cytokine Levels and Haemostatic and Biochemical Parameters in A Rat Endotoxaemic Model


Cite

1. Al-Dughaym A.M.: Some endotoxin-induced clinical and biochemical changes in plasma of camels (Camelusdromedaricus). Vet Res Commun 2004, 28, 711-718.10.1023/B:VERC.0000045956.68656.43 Search in Google Scholar

2. Allam G.: Vasoactive intestinal peptide inhibits liver pathology in acute murine Schistosomiasis mansoni and modulates IL-10, IL-12 and TNF-1 production. Immunobiology 2007, 212, 603-612.10.1016/j.imbio.2007.05.00617869638 Search in Google Scholar

3. Asakura H., Asamura R., Ontachi Y., Hayashi T., Yamazaki M., Morishita E., Miyamoto K.I., Nakao S.: Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats. J Thromb Haemost 2005, 3, 1050-1055.10.1111/j.1538-7836.2005.01248.x15869603 Search in Google Scholar

4. Col R., Keskin E., Atalay B.: Effect of pentoxifylline on endotoxin-induced haemostatic disturbances in rabbits. Acta Vet Hung 2005, 53, 325-335.10.1556/avet.53.2005.3.616156128 Search in Google Scholar

5. Delgado M., Martinez C., Pozo D., Calvo J.R., Leceta J., Ganea D., Gomariz R.P.: Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-a and IL-6. J Immunol 1999, 162, 1200-1205.10.4049/jimmunol.162.2.1200 Search in Google Scholar

6. Delgado M., Pozo D., Martinez C., Leceta J., Calvo J.R., Ganea D., Gomariz R.P.: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-a production by macrophages, in vitro and in vivo studies. J Immunol 1999, 162, 2358-2367.10.4049/jimmunol.162.4.2358 Search in Google Scholar

7. Dhuley J.N., Naik S.R.: Effect of rhinax on bacterial lipopolysaccharide induced endotoxemia in rats. Indian J Exp Biol 1998, 36, 315-317. Search in Google Scholar

8. Fernández-Martínez E., Morales-Ríos M.S., Pérez- Alvarez V., Muriel P.: Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat. Biochem Pharmacol 2004, 68, 1321-1329.10.1016/j.bcp.2004.06.01815345321 Search in Google Scholar

9. Fourrier F., Chopin C., Huart J.J., Runge I., Caron C., Goudemand J.: Double-blind placebo-controlled trial of antithrombin III concentrate in septic shock with disseminated intravascular coagulation. Chest 1993, 104, 882-892.10.1378/chest.104.3.8828365305 Search in Google Scholar

10. Fraunberg P., Schaefer S., Werdan K., Walli A.K., Seidel D.: Reduction of circulating cholesterol and apoliloprotein levels during sepsis. Clin Chem Lab Med 1999, 37, 357-362.10.1515/CCLM.1999.05910353483 Search in Google Scholar

11. Gaviria J.M., Dale D.C., Root R.K.: Neutrophils: function and role in sepsis syndrome. Sepsis 1998, 2, 107-117.10.1023/A:1009717806924 Search in Google Scholar

12. Gonzalez-Rey E., Delgado M.: Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis. Trends Mol Med 2007, 13, 241-251.10.1016/j.molmed.2007.04.00317467339 Search in Google Scholar

13. Grimm M.C., Newman R., Hassim Z., Cuan N., Connor S.J., Le Y., Wang J.M., Oppenheim J.J., Lloyd A.R.: Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by transdeactivating chemokine receptors. J Immunol 2003, 171, 4990-4994.10.4049/jimmunol.171.10.499014607894 Search in Google Scholar

14. Hayashi T., Kishiwada M., Fujii K., Yuasa H., Nishioka J., Ido M., Gabazza E.C., Suzuki K.: Lipopolysaccharide-induced decreased protein S expression in liver cells is mediated by MEK/ERK signaling and NFjB activation: involvement of membrane-bound CD14 and toll-like receptor-4. J Thromb Haemost 2006, 4, 1763-1773.10.1111/j.1538-7836.2006.02042.x16879219 Search in Google Scholar

15. Hopper K., Bateman S.: An updated view of hemostasis: mechanisms of hemostatic dysfuntion associated with sepsis. J Vet Emerg Crit Care 2005, 15, 83-91.10.1111/j.1476-4431.2005.00128.x Search in Google Scholar

16. Iba T., Nakarai .E, Takayama T., Nakajima K., Sasaoka T., Ohno Y.: Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model. Crit Care 2009, 13, R203.10.1186/cc8210281190120003418 Search in Google Scholar

17. Izutani W., Fujita M., Nishizawa K., Koga J.: Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): A comparison with low molecular weight heparin in rats with lipopolysaccharide-induced DIC. Biol Pharm Bull 2000, 23, 1046-1050.10.1248/bpb.23.104610993202 Search in Google Scholar

18. Lauw F.N., Pajkrt D., Hack C.E., Kurimoto M., van Deventer S.J.H., van der Poll T.: Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 2000, 165, 2783-2789.10.4049/jimmunol.165.5.278310946310 Search in Google Scholar

19. Levi M., de Jonge E., van der Poll T.: Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med 2001, 29, 90-94.10.1097/00003246-200107001-0002811445740 Search in Google Scholar

20. Mathiak G., Grass G., Herzmann T., Luebke T., Zetina C.C., Boehm S.A., Bohlen H., Neville L.F., Hoelscher A.H.: Caspase-1-inhibitor ac-YVAD-cmk reduces LPSlethality in rats without affecting haematology or cytokine responses. Br J Pharmacol 2000, 131, 383-386.10.1038/sj.bjp.0703629157236911015286 Search in Google Scholar

21. Møller S., Laigaard F., Olgaard K., Hemmingsen C.: Effect of 1,25-dihydroxy-vitamin D3 in experimental sepsis. Int J Med Sci 2007, 4, 190-195.10.7150/ijms.4.190192515217657282 Search in Google Scholar

22. Pozo D., Guerrero J.M., Calvo J.R.: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1α production and mRNA expression. Cytokine 2002, 18, 35-42.10.1006/cyto.2002.102412090758 Search in Google Scholar

23. Said S.I.: Vasoactive intestinal peptide and nitric oxide: divergent roles in relation to tissue injury. Ann NY Acad Sci 1996, 805, 379-387.10.1111/j.1749-6632.1996.tb17498.x8993418 Search in Google Scholar

24. Saito K., Yamatani K., Manaka H., Takahashi K., Tominaga M., Sasaki H.: Role of Ca2+ on vasoactive intestinal peptide-induced glucose and adenosine 3',5'- monophosphate production in the isolated perfused rat liver. Endocrinology 1992, 130, 2267-2273.10.1210/endo.130.4.1372240 Search in Google Scholar

25. Tuncel N., Tore F., Sahinturk V., Ak D, Tuncel M.: Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock. Peptides 2000, 21, 81-89.10.1016/S0196-9781(99)00177-1 Search in Google Scholar

26. van Devender S.J.H., Buller H.R., ten Cate J.W., Aareden L.A., Hack C.E., Sturk A.: Experimental endotoxemia in humans; analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990, 76, 2520-2526. Search in Google Scholar

27. van Veen S.Q., Cheung C.W., Meijers J.C.M., van Gulik T.M., Boermeester M.A.: Anticoagulant and antiinflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis. J Thromb Haemost 2006, 4, 2343-2351.10.1111/j.1538-7836.2006.02167.x16911675 Search in Google Scholar

28. van Westerloo D.J., Giebelen I.A.J., Meijers J.C.M., Daalhuisen J., de Vos A.F., Levi M., van der Poll T.: Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats. J Thromb Haemost 2006, 4, 1997-2002.10.1111/j.1538-7836.2006.02112.x16805873 Search in Google Scholar

29. Yamazaki M., Aoshima K., Mizutani T., Ontachi Y., Saito M., Morishita E., Asakura H., Matsuda T., Triplett D.A.: Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: İmportance of inflammatory cytokine suppression Blood Coag Fibrinol 1999, 10, 321-330.10.1097/00001721-199909000-0000210493213 Search in Google Scholar

30. Yang H., Li Q.W., Han Z.S., Hu J.H., Li W.Y., Liu Z.B.: Recombinant human antithrombin expressed in the milk of non-transgenic goats exhibits high efficiency on rat DIC model. J Thromb Thrombolysis 2009, 28, 449-457.10.1007/s11239-009-0347-x19455283 Search in Google Scholar

31. Yazar E., Col R., Konyalıoglu S., Birdane Y.O., Elmas M., Bas A.L.: Effects of vitamın E and prednisolone on biochemical and haematological parameters in endotoxaemic New Zealand white rabbits. Bull Vet Inst Pulawy, 2004, 48, 105-108. Search in Google Scholar

32. Yun-Choi H.S., Pyo M.K., Chang K.C., Lee D.H.: The effects of higenamine on LPS-induced experimental disseminated intravascular coagulation (DIC) in rats. Planta Med 2002, 68, 326-329.10.1055/s-2002-2674111988856 Search in Google Scholar

eISSN:
2300-3235
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Microbiology and Virology, other, Medicine, Veterinary Medicine